IDiyas

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Samuel James Dominianni

USPTO Granted Patents = 19

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 123(Granted Patents)


Company Filing History:

goldMedal16 out of 4,442 
 
Eli Lilly and Company
 patents
silverMedal3 out of 832,680 
Other
 patents

Years Active: 1978-2008

Loading Chart...
19 patents (USPTO):
1. 7351728 - Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists (2008-04-01),
2. 7304062 - Peroxisome proliferator activated receptor alpha agonists (2007-12-04),
3. 6982278 - Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists (2006-01-03),
4. 6825222 - Modulators of peroxisome proliferator activated receptors (2004-11-30),
5. 6617343 - Hypoglycemic N,N-arylsulfonylglycine compounds (2003-09-09),
6. 6617342 - Hypoglycemic sulfonyl pyrazolones and pyrazolines (2003-09-09),
7. 6610696 - Modulators of peroxisome proliferator activated receptors (2003-08-26),
8. 6541497 - Hypoglycemic and hypolipidemic compounds (2003-04-01),
9. 6417212 - Modulators of peroxisome proliferator activated receptors (2002-07-09),
10. 6353027 - Hypoglycemic and hypolipidemic compounds (2002-03-05),
11. 6194446 - Hypoglycemic and hypolipidemic compounds (2001-02-27),
12. 6121282 - Hypoglycemic and hypolipidemic compounds (2000-09-19),
13. 5641796 - Oral hypoglycemic agents (1997-06-24),
14. 4683312 - Imidazolium hypoglycemic agents (1987-07-28),
15. 4629811 - 3-sulfonylamino-4-aminobenzophenone derivatives (1986-12-16),

Title: The Innovative Journey of Samuel James Dominianni

Introduction:

Samuel James Dominianni, a prolific inventor hailing from Indianapolis, IN (US), has made significant contributions to the field of pharmaceuticals with a total of 19 patents under his belt. His groundbreaking work has focused on developing compounds for the treatment of diabetes mellitus and other related conditions.

Latest Patents:

Samuel James Dominianni's latest patents include Oxazolyl-aryloxyacetic acid derivatives and Peroxisome proliferator activated receptor alpha agonists. These compounds have shown promise in modulating peroxisome proliferator activated receptors, particularly in the context of diabetes treatment.

Career Highlights:

Having worked at prestigious companies like Eli Lilly and Company, Samuel James Dominianni has honed his skills and expertise in the pharmaceutical industry. His innovative mindset and dedication to scientific advancements have led to the successful development of various patented compounds.

Collaborations:

Throughout his career, Samuel James Dominianni has collaborated with esteemed professionals in the field. Notable coworkers include Dawn Alisa Brooks and Alan M Warshawsky, who have been instrumental in the research and development processes of his patented compounds.

Conclusion:

Samuel James Dominianni's innovative spirit and relentless pursuit of scientific excellence have cemented his position as a leading inventor in the pharmaceutical arena. His contributions towards developing novel compounds for diabetes treatment exemplify his commitment to advancing healthcare and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…